Assertio (ASRT) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Assertio Reports Second Quarter 2024 Financial Results Second Quarter Total Net Product Sales of $30.7 Million Rolvedon Growth Continues, with$15.1 million in Net Product Sales $7.4 Million in Cash Flow from Operations, Cash and Short-Term Investments Increases to$88.4 Million LAKE FOREST, IL. – August 7, 2024 – Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, ...